CHU Helora
CHU Helora
La Louvière, Belgium2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older | diffuse large B-cell lymphoma | Active, not recruiting | Phase 2 | 2026-06-04 | NCT04974216 | |
| Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, injury, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor, radiation injury | Recruiting | Not applicable | 2026-02-27 | NCT06719440 |